- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Indolent Systemic Mastocytosis
Total 189744 results
-
Fondazione Italiana Linfomi - ETSActive, not recruitingIndolent B-Cell LymphomasFrance, Italy, Brazil, Austria, Portugal, Ukraine
-
Novartis PharmaceuticalsCompletedChronic Myelomonocytic Leukemia | Hypereosinophilic Syndrome | Systemic Mastocytosis | DermatofibrosarcomaAustralia
-
GT Biopharma, Inc.TerminatedAcute Myelogenous Leukemia | Systemic Mastocytosis | Mast Cell Leukemia | High-risk Myelodysplastic SyndromesUnited States
-
Ohio State University Comprehensive Cancer CenterCompletedIndolent or Intermediate Grade B-cell MalignancyUnited States
-
University of British ColumbiaNot yet recruitingMitochondrial DNA Deletion | Macrocytosis
-
Stanford UniversityNational Cancer Institute (NCI); The Leukemia and Lymphoma SocietyCompletedLeukemia, Mast-Cell | Mantle-cell LymphomaUnited States
-
Central Hospital, Nancy, FranceUnknown
-
Poitiers University HospitalCompletedMast Cell Activation Syndrome | Urticaria Pigmentosa | Mast Cell Activation Disease | Mast Cell DiseaseFrance
-
University of Michigan Rogel Cancer CenterBristol-Myers Squibb; Bayer; University of Michigan; Big Ten Cancer Research ConsortiumActive, not recruiting
-
National Institute of Allergy and Infectious Diseases...Completed
-
AB ScienceCompleted
-
University of ZurichCompleted
-
Novartis PharmaceuticalsCompletedHypereosinophilic Syndrome | Chronic Myelogenous Leukemia | Systemic Mastocytosis | Acute Lymphoblastic Leukemia (Philadelphia Chromosome Positive)United States, Poland, Italy, Belgium, Canada, France, Australia, Netherlands, Sweden, Switzerland, United Kingdom, Spain, Korea, Republic of, Austria, Germany, Denmark, Finland, Singapore, Taiwan, Hong Kong, New Zealand, Norway
-
German Low Grade Lymphoma Study GroupTerminatedIndolent LymphomaGermany
-
National Institute of Allergy and Infectious Diseases...Completed
-
Indiana UniversityRecruitingBreast Cancer | Indolent Metastatic Breast CancerUnited States
-
University Hospital, ToulouseNot yet recruiting
-
Tel-Aviv Sourasky Medical CenterKaMaH - The Center for Health-Promoting TherapiesRecruitingIndolent LymphomaIsrael
-
Prof. Dr. Wolfgang HiddemannHoffmann-La Roche; Mundipharma Research GmbH & Co KGCompleted
-
MacroGenicsRecruitingMyelodysplastic Syndromes | Chronic Myeloid Leukemia | Classical Hodgkin Lymphoma | Blastic Plasmacytoid Dendritic Cell Neoplasm | Leukemia, B-cell | Leukemia, Hairy Cell | Leukemia, Acute Myeloid | Mastocytosis, Aggressive SystemicUnited States
-
Shanghai YingLi Pharmaceutical Co. Ltd.Not yet recruitingIndolent B-cell Lymphoma
-
AB ScienceCompleted
-
University of MichiganCompleted
-
National Institute of Allergy and Infectious Diseases...Completed
-
Cancer Institute and Hospital, Chinese Academy...Shanxi Province Cancer Hospital; Beijing Tongren Hospital; Fujian Medical University...Recruiting
-
Medical University of LublinRecruitingMastocytosis | BonesPoland
-
PrECOG, LLC.Genentech, Inc.TerminatedIndolent Non-Hodgkin's LymphomaUnited States
-
Gruppo Italiano Studio LinfomiUnknown
-
National Institute of Allergy and Infectious Diseases...RecruitingMastocytosis | Bone Marrow | Monoclonal | TryptaseUnited States
-
National Taiwan University HospitalUnknown
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaKorea, Republic of, Czechia, United States, United Kingdom, Italy, Poland, Russian Federation, Germany
-
Ludwig-Maximilians - University of MunichHoffmann-La Roche; Janssen-Cilag G.m.b.HActive, not recruitingIndolent Non-Hodgkin LymphomaGermany
-
Fondazione Italiana Linfomi ONLUSCompletedNon-Hodgkin's Lymphoma | Indolent Non-follicularItaly
-
University Hospital, ToulouseUnknownMastocytosis | CutaneousFrance
-
Hebei Senlang Biotechnology Inc., Ltd.RecruitingRefractory Indolent Adult Non-Hodgkin LymphomaChina
-
SecuraBioCompletedIndolent Non-Hodgkin LymphomaBelgium, France, Italy, Spain, Canada, United States, Bulgaria, United Kingdom, Hungary, Georgia, Belarus, Czechia
-
AB ScienceRecruitingMast Cell Activation SyndromeFrance, United States
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Hungary, United Kingdom, Australia, Singapore, Japan, Taiwan, Israel, Italy, Spain, Czechia, Russian Federation, France, Poland, Romania, Germany, Portugal, Sweden
-
Centre Antoine LacassagneTerminatedMalignant Mast Cell Tumors | Solid Organ SitesFrance
-
S*BIOCompletedHodgkin Lymphoma | Mantle Cell Lymphoma | Indolent LymphomaUnited States, Canada
-
Huiqiang HuangRecruitingLymphoma, B-CellChina
-
BayerActive, not recruitingRelapsed or Refractory Indolent Non-Hodgkin LymphomaTaiwan
-
Blueprint Medicines CorporationPatientCrossroadsCompleted
-
Massachusetts General HospitalDana-Farber Cancer Institute; Genentech, Inc.; Brigham and Women's HospitalCompletedB-cell Lymphoma | Indolent B-cell LymphomaUnited States
-
Ronald LevyPfizerCompletedLymphoma | Lymphoma, Non-Hodgkin | Lymphomas: Non-Hodgkin | Lymphomas: Non-Hodgkin Follicular / Indolent B-CellUnited States
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Canada, Spain, Taiwan, France, Australia, United Kingdom, Poland, Italy, Israel, Czechia, Germany, Russian Federation, Sweden
-
GlaxoSmithKlineCompleted
-
Mundipharma Research LimitedTerminatedIndolent B-cell NHLAustralia, Slovakia